Chronic kidney disease trials recruiting in Maryland

All Chronic kidney disease trials nationally

Cities in Maryland

Recruiting trials in Maryland

• A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
  NCT05321368 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore, Denton
• A Natural History Study of Metabolic Sizing in Health and Disease
  NCT05398783 · Phase: Not specified · Ages: 2 Years to 99 Years · Sex: All (male and female) · Maryland: Bethesda
• A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
  NCT06830629 · Phase: Phase 2 · Ages: 18 Years to 68 Years · Sex: All (male and female) · Maryland: Arnold, Lutherville, Oxon Hill
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Bethesda
• A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
  NCT06749457 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Maryland: Baltimore
• A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
  NCT04671771 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female) · Maryland: Baltimore
• A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
  NCT07107945 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Maryland: Baltimore
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Beltsville
• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
  NCT05457283 · Phase: Phase 3 · Ages: 1 Year to 18 Years · Sex: All (male and female) · Maryland: Baltimore
• An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
  NCT05106387 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · Maryland: Baltimore
• CAPABLE Transplant
  NCT06326905 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · Maryland: Baltimore
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · Maryland: Baltimore, Bethesda, Clinton, Easton
• Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
  NCT01087333 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Bethesda
• Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
  NCT03803423 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
  NCT06712407 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength
  NCT06607913 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Immune System Related Kidney Disease
  NCT00001979 · Phase: Not specified · Ages: 10 Years to 99 Years · Sex: All (male and female) · Maryland: Bethesda
• Incremental Hemodialysis: The TwoPlus Trial
  NCT05828823 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Kidney Precision Medicine Project
  NCT04334707 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Transforming Hemodialysis-Related Vascular Access Education
  NCT05997875 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore